GENERIC NAME OF THE MEDICINAL PRODUCT:

A) Nitroglycerin Controlled Release Tablets 2.6mg
B) Nitroglycerin Controlled Release Tablets 6.4mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Nitroglycerin Controlled Release Tablets 2.6mg
Each uncoated tablet contains:
Diluted Nitroglycerin IP
Equivalent to Nitroglycerin…………………2.6mg
(In a controlled release system)
Excipients…………………………………………………q.s.
Colours: Lake tartrazine

B) Nitroglycerin Controlled Release Tablets 6.4mg
Each uncoated tablet contains:
Diluted Nitroglycerin IP
Equivalent to Nitroglycerin…………………2.6mg
(In a controlled release system)
Excipients…………………………………………………q.s.
Colours: Helendon pink aluminum lake


THERAPEUTIC INDICATIONS:

Nitroglycerin tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). It is also used just before activities that may cause episodes of angina in order to prevent the angina from occurring.

CAUTION & SCHEDULE:

CAUTION:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
SCHEDULE: SCHEDULE H:TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.

STORAGE & DOSAGE:

Storage: Store below 30°C.
Protect from Light and moisture.
Dosage: As directed by the Physician

Nitroglycerin Controlled Release Tablets 6.4mg Technical Specification:

Product Name: Nitroglycerin Controlled Release Tablets
Brand Name: Generic
Strength: 2.6mg, 6.4mg
Dosage Form: Tablets (Uncoated)
Route of Administration: Via Oral Route
Packing: 10s, 30s, 100s, 500s
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Antianginal, Cardiovascular
Indication: Nitroglycerin is used to prevent angina (chest pain) caused by coronary artery disease.
Storage: Store below 30°C. Protect from Light.

GENERIC NAME OF THE MEDICINAL PRODUCT:

A) Nitroglycerin Controlled Release Tablets 2.6mg
B) Nitroglycerin Controlled Release Tablets 6.4mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Nitroglycerin Controlled Release Tablets 2.6mg
Each uncoated tablet contains:
Diluted Nitroglycerin IP
Equivalent to Nitroglycerin…………………2.6mg
(In a controlled release system)
Excipients…………………………………………………q.s.
Colours: Lake tartrazine

B) Nitroglycerin Controlled Release Tablets 6.4mg
Each uncoated tablet contains:
Diluted Nitroglycerin IP
Equivalent to Nitroglycerin…………………6.4mg
(In a controlled release system)
Excipients…………………………………………………q.s.
Colours: Helendon pink aluminum lake

THERAPEUTIC INDICATIONS:

Nitroglycerin tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). It is also used just before activities that may cause episodes of angina in order to prevent the angina from occurring.

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.

SCHEDULE: SCHEDULE H:TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.

STORAGE & DOSAGE:

Storage: Store below 30°C.
Protect from Light and moisture.
Dosage: As directed by the Physician